The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey.

Ilana Levy YurkovskiGiora SharfShlomit NormanTamar Tadmor

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)

The management of hematological malignancies during pandemics should always take into consideration patients' fears, as well as the development of depression related to isolation and loneliness, in addition to the high risk of severe disease. Patients with CML had a high rate of depression which obviously needs to be managed very carefully during and after the COVID-19 pandemic.

Keyphrases

end stage renal disease
depressive symptoms
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
sars cov
sleep quality
early onset
social support
drug induced
patient reported
chronic myeloid leukemia